Insight Molecular Diagnostics (IMDX) Liabilities from Discontinued Operations (2021 - 2023)
Insight Molecular Diagnostics (IMDX) posted Liabilities from Discontinued Operations of 45000.0 for Q4 2023, down 50.0% sequentially from 90000.0 in Q3 2023, and down 97.76% YoY from 2005000.0 in Q4 2022.
Insight Molecular Diagnostics (IMDX) Liabilities from Discontinued Operations (2021 - 2023) Analysis & Trends
Insight Molecular Diagnostics has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 45000.0 in Q4 2023.
- Quarterly Liabilities from Discontinued Operations fell 97.76% year-over-year to 45000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 45000.0 (down 97.76% YoY) and the FY2023 annual result came in at 45000.0, down 97.76% from the prior year.
- Liabilities from Discontinued Operations declined to 45000.0 in Q4 2023 per IMDX's latest filing, from 90000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 2005000.0 in Q4 2022 and troughed at 45000.0 in Q4 2023.
- A 3-year average of 672833.33 and a median of 185500.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
- The sharpest annual moves came in 2022 and 2023: Liabilities from Discontinued Operations surged 31.39% in 2022, then slumped 97.76% in 2023.
- Over 3 years, Liabilities from Discontinued Operations stood at 1526000.0 in 2021, then soared by 31.39% to 2005000.0 in 2022, then plunged by 97.76% to 45000.0 in 2023.
- According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 45000.0, 90000.0, and 135000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 45,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 135,000.00 |
| Jun 30, 2023 | 135,000.00 |
| Mar 31, 2023 | 236,000.00 |
| Mar 31, 2023 | 236,000.00 |
| Dec 31, 2022 | 2.01 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Dec 31, 2021 | 1.53 Mn |